VRTX (VRTX) Stock Price & Analysis
VRTX (VRTX) rose 0.00% to USD 477.36 as of July 25, 2026 at 01:12 UTC, according to Nexqual real-time market data.
VRTX last closed at USD 477.36; the session ranged USD 472.58–484 on volume of 1,253,910 shares. Market capitalization is —, with a 52-week range of USD 362.5–533.67 (NMS). Source: Nexqual, July 25, 2026 at 01:12 UTC.
Key Statistics (as of July 25, 2026 at 01:12 UTC)
| Price | USD 477.36 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 477.36 |
| Open | USD 477.36 |
| Day Range | USD 472.58 – 484 |
| 52-Week Range | USD 362.5 – 533.67 |
| Volume | 1,253,910 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (VRTX)
Nexqual's technical model rates VRTX "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 01:12 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 49.66 (neutral) |
| vs SMA50 | Above (USD 464.3) |
| MACD | 2.26 (positive) |
From VRTX's Latest SEC 10-K Filing (filed 2026-02-13)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | USD 656.01 | ▲ 0.74% |
| BIIB | Biogen Inc. | USD 202.19 | ▲ 2.25% |
| INCY | Incyte Corporation | USD 117.67 | ▲ 1.62% |
| ILMN | Illumina, Inc. | USD 194.09 | ▲ 1.69% |
| BMRN | BioMarin Pharmaceutical Inc. | USD 59.33 | ▲ 1.59% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:12 UTC. This page is informational and not investment advice.